Table 4.
Initial model
|
‘Type of atrophy’ model
|
‘Type of inflammation’ model
|
||||
---|---|---|---|---|---|---|
OR (95% CI) | P-value | OR (95% CI) | P-value | OR (95% CI) | P-value | |
PSA (ng/ml) | 1.08 (1.05–1.11) | < 0.001 | 1.08 (1.05–1.11) | < 0.001 | 1.08 (1.05–1.11) | < 0.001 |
HGPIN | 2.33 (1.41–3.83) | 0.001 | 2.30 (1.39–3.80) | 0.001 | 2.23 (1.36–3.67) | 0.002 |
Presence of atrophy | 1.30 (1.02–1.67) | 0.04 | 1.28 (1.00–1.64) | 0.05 | ||
Simple atrophy | 1.33 (1.03–1.70) | 0.03 | ||||
Post-atrophic hyperplasia | 2.03 (0.68–6.04) | 0.20 | ||||
Partial atrophy | 0.92 (0.39–2.15) | 0.84 | ||||
Presence of inflammation | 0.59 (0.46–0.77) | < 0.001 | 0.59 (0.45–0.77) | < 0.001 | ||
Stromal inflammation | 0.63 (0.49–0.83) | < 0.001 | ||||
Glandular inflammation | 1.12 (0.76–1.67) | 0.57 | ||||
Periglandular inflammation | 0.93 (0.68–1.27) | 0.65 |